Tony Hagen, Senior Editor, The Center for Biosimilars

home / authors / tony-hagen-senior-editor-center-biosimilars

Articles

AMCP Nexus 2021: Cate Lockhart of Biologics and Biosimilars Collective Intelligence Consortium Discusses Biosimilars Such as Semglee and the Current Standing of Biosimilars, PBMs

AMCP Nexus 2021: Cate Lockhart of Biologics and Biosimilars Collective Intelligence Consortium Discusses Biosimilars Such as Semglee and the Current Standing of Biosimilars, PBMs

Tony Hagen, Senior Editor, The Center for Biosimilars
October 20th 2021

Cate Lockhart, Pharm.D., Ph.D., spoke at AMCP Nexus about biosimilars, the insulin biosimilar Semglee and the role of PBMs.

Read More

AMCP Nexus 2021: Jen Norton, VP & Head of U.S. Value & Access at Amgen Talks Biosimilar Trends and What to Expect in the Next Year

AMCP Nexus 2021: Jen Norton, VP & Head of U.S. Value & Access at Amgen Talks Biosimilar Trends and What to Expect in the Next Year

Tony Hagen, Senior Editor, The Center for Biosimilars
October 19th 2021

Jen Norton spoke at AMCP Nexus about biosimilar trends of 2021 and what to expect in the next 12 months

Read More

FDA Issues Contingency Guidance for Clinical Trials Affected by COVID-19

FDA Issues Contingency Guidance for Clinical Trials Affected by COVID-19

Tony Hagen, Senior Editor, The Center for Biosimilars
March 19th 2020

CROs are also adapting to pandemic.

Read More

Latest Updated Articles

man looking at screen with gene images | ©muhammad stock.adobe.com
Published: December 10th 2024 | Updated: December 24th 2024
Next-Generation Testing Cheaper and More Effective for Guiding Lung Cancer Treatment
Pills balancing on top of each other | Image credit: James Thew - stock.adobe.com
Published: July 20th 2020 | Updated: December 24th 2024
For Better HCQ Retinopathy Guidelines, Include Prescribing Physicians
K-Cast Written Summary. Diabetes Quality Measures Have Challenges But Also Successes
Published: October 3rd 2024 | Updated: December 24th 2024
K-Cast Written Summary. Diabetes Quality Measures Have Challenges But Also Successes
K-Cast Written Summary. Key Patient Considerations for Use of Intravenous and Subcutaneous Therapies
Published: October 7th 2024 | Updated: December 24th 2024
K-Cast Written Summary. Key Patient Considerations for Use of Intravenous and Subcutaneous Therapies
K-Cast Written Summary. Optimizing the Management of Myelofibrosis
Published: November 7th 2024 | Updated: December 24th 2024
K-Cast Written Summary. Optimizing the Management of Myelofibrosis
K-Cast Written Summary. FDA-Approved Treatment for Demodex Bepharitis Shortens Treatment, Improves Quality of Life
Published: July 11th 2024 | Updated: December 24th 2024
K-Cast Written Summary. FDA-Approved Treatment for Demodex Bepharitis Shortens Treatment, Improves Quality of Life
© 2024 MJH Life Sciences

All rights reserved.